May 15, 2020

The COS has developed this checklist on reopening ophthalmology clinics during COVID-19. This document has been reviewed and endorsed by our affiliate subspecialty societies, provincial societies and ACUPO.

Read the full checklist on reopening ophthalmology clinics during COVID-19

Détails du webinaire

Date: Lundi, 11 mai 2020
Heure : 12 h HAE

S’inscrire au webinaire Vous devez au préalable vous inscrire ici.

Conférencière Dre Diane Francoeur Présidente, Fédération des médecins spécialistes du Québec

Modérateur

• Dr Sam Daniel Directeur, Direction du développement professionnel continu
• Jacques Tétrault, Directeur Affaires publiques et Communications, FMSQ

Objectifs d’apprentissage

À la fin de cette conférence, les participants seront en mesure :

• Décrire la situation actuelle concernant la pandémie de COVID-19;
• Discuter des plus récentes recommandations concernant la prise en charge du COVID-19;
• Ajuster sa pratique afin de répondre à ses responsabilités personnelles et professionnelles.

May 5, 2020

Guidance During COVID-19: Disinfection Recommendations from the Manufacturers – Haag-Streit and Zeiss

Access Details

• COVID-19 guidance: Cleaning your HFA Perimeter
• Considerations on How to Clean Perimeters to Lower the Risk of COVID 19 Transmissions
• Cleaning Guidance for the Humphrey Field Analyzer (HFA)

April 30, 2020

The CRS Executive has reviewed and supports the recommendations of the American Society of Retinal Specialists (ASRS) for conducting vitreoretinal surgery during the COVID-19 pandemic. The CRS endorses these ASRS recommendations for application within the Canadian context.

Read the full ASRS recommendations for conducting vitreoretinal surgery during the COVID-19 pandemic

April 28, 2020

Guidelines on Personal Protective Equipment (PPE) during COVID-19 Pandemic for Oculoplastic and Orbital Surgery

Background

The Canadian Society of Oculoplastic Surgery has evaluated the current literature assessing the risk to ophthalmologists who perform oculoplastics procedures during and after the current pandemic.   Using the best evidence available, guidelines on the minimum personal protective equipment that surgeons should employ were developed. The attached statement has been endorsed by the COS Board of Directors. These comments and recommendations are based on the “conditions on the ground” that exist today at the time of this writing.

Access Details

Read the full position statement from the Canadian Society of Oculoplastic Surgery

COVID-19 Document Library

April 4, 2020

Background

At the Association of Canadian University Professor of Ophthalmology (ACUPO) teleconference on March 24, 2020, Canadian Department Heads were interested in developing recommendations to assist balancing crucial reductions in anti-VEGF treatment volumes, driven by the COVID-19 virus, with essential treatments still needed for sight preservation. Following a literature review focusing on randomized clinical trials, the following recommendations were developed. Subsequently, the document was reviewed by ACUPO and the Canadian Ophthalmological Society (COS) for feedback.

This document Additional Considerations to Help Manage the Anti-VEGF Injection Burden during the COVID-19 Pandemic is supplementary to and expands on the foundational CRS March 19, 2020 Canadian Retina Society (CRS) Position Statement on Intravitreal Injections and the Management of Retinal Diseases during the COVID-19 Crisis. Both documents can be found on the COS Practice Resource Center. The data and suggestions that follow, as always, do not replace appropriate clinical judgement; clinicians will need to consider the specifics of each patient’s unique ocular and systemic health status and provide care that is in the patient’s best interest.  

Access Details

Read the full statement for the Additional Considerations to Help Manage the Anti-VEGF Injection Burden during the COVID-19 Pandemic.

April 16, 2020

Background

The COVID-19 Pandemic has led to widespread implementation of physical isolating measures and cessation of non-urgent medical visits and procedures. This document is to provide guidance to physicians caring for glaucoma patients to help mitigate the risk to patient and care provider while balancing the need for treatment to preserve vision. As this is a rapidly evolving health care crisis, these recommendations may be modified, and we urge all clinicians to use their own best judgement to individually manage patient care with best practices in mind.  These recommendations are based upon and supplemental to the March 20, 2020 COS and ACUPO Guidelines for Ophthalmic Care during COVID-19 Pandemic and guidelines from American Academy of Ophthalmology, and the United Kingdom National Health Society guidelines.

Access Details

Read the full recommendations from the Canadian Glaucoma Society.

The Canadian Glaucoma Society Recommendations for Providing Eye Care to Glaucoma Patients During COVID-19 Pandemic was endorsed by the Canadian Ophthalmological Society (COS) and the Association of Canadian University Professors of Ophthalmology (ACUPO) on April 9, 2020.

March 20,2020

Background

We are in the midst of a global crisis, which changes daily. Our federal, provincial, local, hospital, and university authorities provide mandates and recommendations that are applicable to the practice of medicine during the COVID-19 pandemic. The purpose of the guidelines below is not to replace those mandates and recommendations, but to add those specifically relevant to the practice of ophthalmology. The guidelines reflect a collaborative effort among the Canadian Ophthalmological Society, the Association of Canadian University Professors of Ophthalmology, and subspecialty societies. The American Academy of Ophthalmology guidelines at www.aao.org/headline/alert-important-coronavirus-context  are also useful for the context of ophthalmic care, and were useful in the development of the guidelines below.

Access Details

Read the full COS and ACUPO Guidelines for Ophthalmic Care during COVID-19 Pandemic